Results 241 to 250 of about 44,809 (280)
Some of the next articles are maybe not open access.
2001
Despite the impressive advances in our understanding of the basic mechanism of sepsis, mortality associated with sepsis remains high. Some experimental and clinical evidence suggests that hemofiltration or other technics commonly used in the continuous renal replacement therapies are able to remove sepsis mediators, although the precise mechanism ...
Giorgio, Berlot +4 more
openaire +6 more sources
Despite the impressive advances in our understanding of the basic mechanism of sepsis, mortality associated with sepsis remains high. Some experimental and clinical evidence suggests that hemofiltration or other technics commonly used in the continuous renal replacement therapies are able to remove sepsis mediators, although the precise mechanism ...
Giorgio, Berlot +4 more
openaire +6 more sources
Current Opinion in Hematology, 1996
Considerable work has been carried out over the past 25 years to define the conditions for application of plasmapheresis or plasma exchange. The use of plasma exchange in neurologic disorders such as Guillain-Barré syndrome has seen widespread application including the combination of plasma exchange with the use of intravenous immunoglobulin ...
G, Rock, N A, Buskard
openaire +2 more sources
Considerable work has been carried out over the past 25 years to define the conditions for application of plasmapheresis or plasma exchange. The use of plasma exchange in neurologic disorders such as Guillain-Barré syndrome has seen widespread application including the combination of plasma exchange with the use of intravenous immunoglobulin ...
G, Rock, N A, Buskard
openaire +2 more sources
Plasmapheresis Therapy in Macroglobulinemia
Annals of Internal Medicine, 1962Excerpt A marked increase in serum viscosity may be responsible for many of the disease manifestations of pathologic states associated with elevated serum macroglobulin levels.
John L. Fahey, Alan Solomon
openaire +3 more sources
Peritoneal Membrane Plasmapheresis
ASAIO Journal, 1992A novel process has been devised that uses the peritoneal membrane to remove plasma proteins from the body at a rate comparable to conventional extracorporeal plasma-pheresis. A vasodilator (4 mg histamine phosphate) is added to 1 liter of hypertonic solution (485 mOsmol/L), and infused intraperitoneally with a residence time of 4 hr. Plasma containing
Jack W. Moncrief +2 more
openaire +4 more sources
Removal of Basiliximab by Plasmapheresis
American Journal of Kidney Diseases, 2001Basiliximab is a chimeric monoclonal antibody directed against the alpha chain of interleukin-2 (IL-2) receptors. Given its expected volume of distribution (plasma volume), therapeutic plasmapheresis may be expected to lower serum Basiliximab levels. A 20-mg dose of Basiliximab was given before plasmapheresis.
Herwig Ulf Meier-Kriesche +5 more
openaire +3 more sources
Plasmapheresis in Solar Urticaria [PDF]
Dermatology, 1991 Three patients with solar urticaria were treated with plasmapheresis. By intradermal injection of in vitro irradiated serum the existence of a circulating photoallergen was demonstrated in cases 1 and 2 but not in case 3. Plasmapheresis induced complete remission of solar urticaria in case 1 and transient improvement in case 2.
Gerd Plewig +4 more
openaire +3 more sources
Clinics in Rheumatic Diseases, 1982
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +3 more sources
SUMMARY AND CONCLUSIONS The growing number of anecdotal reports on the effect of plasmapheresis in patients with active SLE suggests that plasmapheresis, particularly in combination with cytotoxic drugs, merits further exploration as a therapeutic modality.
openaire +3 more sources
Plasmapheresis: Technique and complications
Intensive Care Medicine, 1990Plasmapheresis has been used in an increasing number of diverse conditions over the past 15 years, and patients on intensive care units are sometimes so treated. This article reviews the principles, different techniques and refinements available, including the more specific methods of antibody removal, such as immunoadsorption.
P. M. Reimann, P. D. Mason
openaire +3 more sources
Plasmapheresis for neurological disorders
Expert Review of Neurotherapeutics, 2009Apheresis is a general term that describes removal of abnormal blood constituents by extracorporeal blood purification methods. To date, therapeutic plasma exchange (PE) is the most common apheresis procedure. Here, plasma is separated from corpuscular blood constituents and replaced with a substitution fluid.
Ralf A. Linker +2 more
openaire +3 more sources
DeckerMed Nephrology, Dialysis, and Transplantation, 2002
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +3 more sources
Plasmapheresis has been applied over the last several decades as primary or adjunctive treatment for a number of primary renal diseases and systemic conditions with renal involvement. The present review discusses renal conditions for which plasmapheresis may be attempted with recommendations based on evidence from the literature.
openaire +3 more sources